Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline vs Celecoxib as Adjunctive Treatment in Treatment-Resistant Major Depressive Disorder
NCT07804979Completed
- Sponsor
- Lahore General Hospital
- Start
- May 2022
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Randomised trial of minocycline and celecoxib oral solution in treatment-resistant depression (TRD) (2 arms), sponsored by Lahore General Hospital. Primary endpoint: Change in Hamilton Depression Rating Scale Score at 12 weeks. Started May 2022; status: completed.
02
Drugs
minocyclinecelecoxib oral solution
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT07804979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804979.